Class
STUDIES of the expression of major histocompatibility complex (MHC) class I genes during murine embryonic development have shown that MHC class I messages and surface class I antigens begin to be detected after the midsomite stage of embryonic development [1, 2] . The levels of MHC class I mRNA and surface antigens remain very low during the entire period of gestation. The surface MHC class I antigens expressed after midsomite stage are predominantly classic H-2 antigens. An extensive search for Qa antigen expression in embryos at various stages after blastocyst with monoclonal antibodies (mAbs) of different reactivities has not yielded positive evidence for Qa surface expression.
It was found that a sharp increase in the levels of MHC class I gene expression occurs during the first week of postnatal development [3] . [4] . The conserved interferon consensus sequence (ICS) is reported to be responsible for elevating transcription of MHC class I genes in interferon-treated cells [8] . The ICS overlaps and juxtaposes with the CRE. Thus, the CRE and ICS are both involved in regulating the transcription of MHC class I genes.
The immune system recognizes self and nonself through differences in MHC antigens and causes rejection of allogenic grafts. However, the immunocompetent mother does not reject her fetus nor even the fetal allograft [9, 10]. As described above, embryos express only low levels of MHC class I antigens before birth [1] . To examine whether such low expression of MHC class I antigens plays a key role in immunological tolerance of the fetus by the mother, we attempted to produce transgenic mice that express MHC class I antigens from early stages of embryonic development.
Materials and Methods
Construction of Ac-Ld plasmid DNA 
MHC class I heavy chain transgenic mice
First, we replaced the promoter for the mouse MHC class I gene H-2Ld with the Ac promoter [13] . The resulting plasmids, designated pAc-Ld, were linearized by restriction enzymes (Fig. 2, up- per panel) and used for microinjection into oocytes of C57BL/6 mice.
Screening by PCR and Southern analysis of tail DNA identified three Ac-Ld transgenic mice. Transgene expression in these mice was examined by Northern blot analysis using an Ac-Ld specific oligonucleotide (Fig. 3) . The result revealed that Fig. 1 . Expression of the Ac-lacZ gene in early mouse embryos. Several hundred copies of pSV-lacZ, pAc-IacZ or pRSV-lacZ plasmid DNA were microinjected into fertilized mouse eggs. On the next day, the embryos at two-cell stage were stained with X-gal as described [19] . 
Normal
Ac-Ld Fig. 3 . Northern blot analysis of Ac-Ld transgenic mice. Total RNA prepared from various tissues of a 6 week-old Ld transgenic mouse and a nontransgenic littermate was subjected to agarose gel electrophoresis followed by transfer to a nylon membrane and hybridization with a 32P-labeled Ac-Ld specific oligonucleotide probe: 5'-GCTTGGCTGGCTGTGGGAGTA-3'. Ac-Ld transcripts are indicated by an arrowhead. 1, thymus; 2, spleen; 3, liver; 4, kidney; 5, brain; 6, muscle; 7, intestine. CAG promoter (Fig. 2 , lower panel) to attain higher and ubiquitous BMG expression. Expression of BMG in these transgenic mice was examined by Northern blot analysis (Fig. 5) . The results showed that BMG mRNA from the trangene was expressed at high levels in all the tissues examined, while the endogenous BMG mRNA was expressed mainly in spleen, thymus and liver. 12.
